Cellected was established to help scientists working with iPSCs

There is growing recognition of the importance of iPSC quality and genetic integrity.  However, the traditional assays used to assess this are lengthy and time-consuming.

Cellected was established to help iPSCs scientists with improving the quality and genetic integrity of the cell lines they work with on a day-to-day basis.

Our innovative services RIQUEST and RESCUE make in-process QC for iPSCs possible, and offer a solution for cell lines with genetic integrity problems.  Together they drive improved reproducibility and reliability in the field, allowing researchers to focus on their complex research whether it is in the field of cell therapy, drug discovery, gene editing, regenerative medicine or organoids.

Cell biology is complex!  As a team we are drawn to helping others with the challenges of iPSCs – and are proud of our novel RESCUE service.

The team also has extensive experience with other cell lines and solving numerous cell biology technical challenges. We can also put our sophisticated technology to use for any cell line.

So, whether you have an iPSC challenge or other cell line challenge – then contact us

Meet the team.

Some of the iPSC experts working at Cellected

Dr Claire Richards
CEO & Co-Founder

Claire did her PhD at Cambridge in the Wellcome Trust Sanger Institute in the Cancer Genome Project. She subsequently joined Horizon Discovery as Team Leader in Cell Line Engineering, using CRISPR and rAAV editing techniques, and was Head of Biology at Solentim, where she developed expertise in automated single-cell cloning, imaging & developed their iPSC workflow.

Nick Adams
Chairman & Co-Founder

Nick recently completed a Masters in Cell & Gene Therapy at UCL. He is Chairman of two other Private Equity / Venture Capital backed Life Science companies. Previously he was CEO of Bioquell PLC, a London-listed applied microbiology business which grew from a small UK business to become a multi-national. Before that he was an investment banker for a decade.

Dr Rosa Loffredo
Team Leader

Rosa did her PhD in experimental and clinical oncology at the University of Florence before working on stem cells as a postdoc at the University of Trento. She moved to lead the iPSC team for the European Collection of Authenticated Cell Cultures at UKHSA (Porton Down) and joined the UKHSA experimental sequencing group during the COVID-19 pandemic.